Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study

Clinical trial NCT04734691 · UNKNOWN

Trial details

NCT number: NCT04734691
Sponsor: Sleiman Marwan-Julien
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Peritoneal Carcinomatosis

Start date: 2021-10-01
Primary completion: 2024-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.